Back to Search
Start Over
Editorial: real‐world evidence of tofacitinib and vedolizumab in ulcerative colitis—are we one step closer to better positioning therapies after anti‐TNF failure?
- Source :
-
Alimentary Pharmacology & Therapeutics . Mar2023, Vol. 57 Issue 6, p733-734. 2p. 1 Chart. - Publication Year :
- 2023
-
Abstract
- LINKED CONTENT: This article is linked to Buisson et al papers. To view these articles, visit https://doi.org/10.1111/apt.17305 and https://doi.org/10.1111/apt.17405 [ABSTRACT FROM AUTHOR]
- Subjects :
- *ULCERATIVE colitis
*VEDOLIZUMAB
Subjects
Details
- Language :
- English
- ISSN :
- 02692813
- Volume :
- 57
- Issue :
- 6
- Database :
- Academic Search Index
- Journal :
- Alimentary Pharmacology & Therapeutics
- Publication Type :
- Academic Journal
- Accession number :
- 162055829
- Full Text :
- https://doi.org/10.1111/apt.17351